Health Canada Approves Nexstim NBS 6 System for Treatment of MDD
06.05.2024 - Press release, Helsinki, 6 May 2024 at 9 AM (EEST) Health Canada Approves Nexstim NBS 6 System for Treatment of MDD Nexstim Plc (NXTMH:HEX) ('Nexstim' or 'Company') has received approval from Health Canada for the marketing and commercial ...